Natural killer (NK) cells are pivotal in the innate immune response against cancer and viral infections, with their presence in tumors correlating to better patient outcomes in various cancers.

Here, BioSpace looks back at the biggest acquisition deals of 2025. Target: Intra-Cellular Therapies Acquisition date: ...

Intra-Cellular Therapies (NASDAQ:ITCI) will release its quarterly earnings report on Wednesday, 2024-10-30. Here's a brief overview for investors ahead of the announcement. Analysts anticipate ...

Alicia Andrews, 21, sits during pre-trial hearing of Charles "Julio Foolio" Jones murder trial. Read full article: Jury selection begins Monday in trial of woman accused of stalking Jacksonville ...

Intracellular peptides, generated predominantly via the ubiquitin–proteasome system, have emerged as critical modulators of cell signalling. These peptides play multifaceted roles, ranging from ...

Shares of Intra-Cellular Therapies (NASDAQ:ITCI) reached a 52-week high on Wednesday after the New York biopharma raised its outlook for its lead product, Caplyta, on the back of better-than-expected ...

Across the recent three months, 14 analysts have shared their insights on Intra-Cellular Therapies (NASDAQ:ITCI), expressing a variety of opinions spanning from bullish to bearish. The table below ...

Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will get $132 per share, valuing the ...

A live and achieved webcast of the Company’s presentation at the Leerink Partners Global Biopharma Conference can be accessed under "Events & Presentations" in the Investor Relations section of the ...

Read full article: Houston Police are investigating a stabbing at a home on West Alabama Street. Read full article: See these Insider Deals for home, beauty and sports enthusiasts Hassle-free PDFs are ...